IRIS
AIMO, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.519
AS - Asia 12.919
EU - Europa 12.660
SA - Sud America 3.870
AF - Africa 328
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 21
Totale 54.350
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.486
SG - Singapore 5.530
RU - Federazione Russa 4.929
BR - Brasile 3.165
CN - Cina 3.044
IT - Italia 2.516
VN - Vietnam 1.743
GB - Regno Unito 1.631
DE - Germania 983
HK - Hong Kong 885
CA - Canada 723
UA - Ucraina 435
IE - Irlanda 429
SE - Svezia 302
IN - India 275
AR - Argentina 274
FI - Finlandia 271
FR - Francia 226
MX - Messico 223
TR - Turchia 218
PL - Polonia 215
BD - Bangladesh 198
ID - Indonesia 183
NL - Olanda 182
IL - Israele 166
ZA - Sudafrica 152
ES - Italia 149
EC - Ecuador 140
JP - Giappone 137
IQ - Iraq 109
PK - Pakistan 101
AT - Austria 97
CO - Colombia 69
DK - Danimarca 69
AE - Emirati Arabi Uniti 60
LT - Lituania 55
UZ - Uzbekistan 53
MA - Marocco 52
PY - Paraguay 52
VE - Venezuela 50
PE - Perù 34
CL - Cile 33
KE - Kenya 30
UY - Uruguay 29
BE - Belgio 28
CH - Svizzera 26
EG - Egitto 26
SA - Arabia Saudita 23
TN - Tunisia 22
AZ - Azerbaigian 19
JO - Giordania 18
RO - Romania 18
EU - Europa 17
IR - Iran 17
BO - Bolivia 16
CZ - Repubblica Ceca 16
DO - Repubblica Dominicana 16
AU - Australia 15
KZ - Kazakistan 15
DZ - Algeria 14
MY - Malesia 11
NZ - Nuova Zelanda 11
CR - Costa Rica 10
HN - Honduras 10
LB - Libano 10
NP - Nepal 10
AL - Albania 9
GE - Georgia 9
NI - Nicaragua 9
PA - Panama 9
AM - Armenia 8
KR - Corea 8
MC - Monaco 8
OM - Oman 8
TW - Taiwan 8
GT - Guatemala 7
GY - Guiana 7
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
TH - Thailandia 7
BB - Barbados 6
BY - Bielorussia 6
CI - Costa d'Avorio 6
HU - Ungheria 6
JM - Giamaica 6
PH - Filippine 6
TT - Trinidad e Tobago 6
PS - Palestinian Territory 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
KW - Kuwait 4
MD - Moldavia 4
ML - Mali 4
SI - Slovenia 4
AO - Angola 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
ET - Etiopia 3
GR - Grecia 3
Totale 54.273
Salva come PNG Salva come JPEG
Città #
Dallas 6.173
Singapore 2.970
Ashburn 1.589
Chicago 1.425
Beijing 1.388
Los Angeles 1.194
Moscow 914
Hong Kong 826
Salt Lake City 606
Ho Chi Minh City 565
Chandler 562
Southend 543
Fairfield 462
San Mateo 451
Buffalo 426
Dublin 423
Houston 390
New York 368
The Dalles 365
Woodbridge 359
Wilmington 355
Hefei 350
Tampa 345
São Paulo 328
Cambridge 320
Seattle 304
Hanoi 300
Elk Grove Village 269
Milan 256
Boardman 250
Portsmouth 242
Falls Church 237
Munich 234
Santa Clara 216
Stevenage 215
Ann Arbor 212
Rome 210
Ottawa 203
Pisa 200
Beauharnois 193
Warsaw 193
Jacksonville 179
Brooklyn 160
Dearborn 156
Lawrence 155
Montreal 152
Florence 148
Tel Aviv 147
London 141
Sterling 133
Istanbul 128
Lancaster 126
Poplar 122
Stockholm 122
Tokyo 122
Denver 120
Dong Ket 117
Orem 114
Frankfurt am Main 108
Rio de Janeiro 106
Johannesburg 103
Phoenix 102
Chennai 101
Mexico City 97
Nuremberg 97
Lappeenranta 95
Miami 94
Atlanta 93
Boston 88
Helsinki 84
Belo Horizonte 79
Dulles 78
Toronto 74
Turku 70
Haiphong 66
San Diego 64
Amsterdam 63
Manchester 60
Brasília 58
Da Nang 58
Ankara 57
Curitiba 54
Bologna 53
Detroit 53
San Francisco 53
Biên Hòa 52
Porto Alegre 52
Council Bluffs 51
Guangzhou 51
Kansas City 51
Washington 50
Quito 48
Mumbai 47
Tashkent 47
Lucca 46
Campinas 45
Querétaro 45
Guayaquil 44
Pittsburgh 44
Naples 43
Totale 32.597
Salva come PNG Salva come JPEG
Nome #
Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study 1.795
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.601
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.515
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 831
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 663
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study 552
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 410
[The use of PROMs (patient-reported outcome measures) and PREMs (patient-reported experience measures) in Cardiology: current state and applications to improve patient care] 336
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 315
Building medical knowledge from real world registries: The case of heart failure 315
A simple echocardiographic score to rule out cardiac amyloidosis 310
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI 306
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 297
"Targeting and Treating Apneas" in "The Breathless Heart: Apneas in Heart Failure" 297
Treating chemoreflex in heart failure: modulation or demolition? 294
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 289
Peripheral reflex feedbacks in chronic heart failure: Is it time for a direct treatment? 286
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers 283
Influence of central apneas and chemoreflex activation on pulmonary artery pressure in chronic heart failure 281
Prognostic Value of Soluble Suppression of Tumorigenicity-2 in Chronic Heart Failure: A Meta-Analysis 278
Targeting Mitochondrial Dysfunction in Chronic Heart Failure: Current Evidence and Potential Approaches 270
Position paper ANMCO: Impiego di vericiguat nello scompenso cardiaco: dalle evidenze al posizionamento terapeutico 269
A simple echocardiographic score to rule out cardiac amyloidosis 261
Using co-creation to develop a cardiology online open course: an effective approach for implementing digital learning 256
Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure 250
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis 249
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 244
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 244
Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure 241
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 239
Cardiac light-chain deposition disease relapsing in the transplanted heart 238
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 236
Sex-related differences in chronic heart failure 236
How to take arms against central apneas in heart failure 235
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 232
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 227
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead 227
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 226
[18F]-florbetaben PET/CT is sensitive for cardiac AL amyloidosis 226
Unmet needs in end-of-life care for heart failure patients 225
Are big data on myocardial infarction enough for small heart failure patients? Lessons from a national registry 223
Approach to the diagnosis and management of patients with cardiac amyloidosis. A consensus document by the Tuscan section of the Italian Association of Hospital Cardiologists (ANMCO) and the Tusco-Umbrian section of the Italian Society of Cardiology (SIC) 222
Screening the health status of people working in a university 221
Body mass index and outcomes in ischaemic versus non-ischaemic heart failure across the spectrum of ejection fraction 221
Predicting readmissions after hospitalization for heart failure: Medical reasoning vs calculators 218
Breathing Not Properly in the oldest old. Is brain natriuretic peptide a poor test for the diagnosis of heart failure in the elderly? 217
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 217
NT-proBNP prognostic value is maintained in elderly and very elderly patients with chronic systolic heart failure 216
[Ten perspectives for research and innovation in cardiac amyloidosis] 215
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 214
Exercise intolerance in heart failure with preserved ejection fraction: A reappraisal of central mechanisms? 213
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 212
Oxidative stress and inflammation in the evolution of heart failure: From pathophysiology to therapeutic strategies 211
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 210
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure 208
Atrial amyloidosis: mechanisms and clinical manifestations 208
Echocardiography-Derived Forward Left Ventricular Output Improves Risk Prediction in Systolic Heart Failure 208
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 208
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 207
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 206
Biomarkers for the diagnosis and management of heart failure 204
Prognostic value of reverse remodelling criteria in heart failure with reduced or mid-range ejection fraction 204
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 202
Cardiac troponins as biomarkers for cardiac disease 199
Amyloid deposits and fibrosis on left ventricular endomyocardial biopsy correlate with extracellular volume in cardiac amyloidosis 199
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 197
Is fat good for arrhythmias in ischemic heart failure? Another face of the obesity paradox 196
Biomarkers for the diagnosis and management of heart failure: New frontiers 196
Eligibility for vericiguat in a real‐world, contemporary heart failure population 195
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 195
Cardiovascular disease and COVID-19: les liaisons dangereuses 194
ANMCO/ELAS/SIBioC Consensus Document: Biomarkers in heart failure 189
Biomarkers for the diagnosis and management of heart failure: Natriuretic peptides 189
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure 189
Amiodarone as a possible therapy for coronavirus infection 188
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 186
Role of Imaging in Cardiomyopathies 184
Clinical and prognostic significance of central and obstructive apnoeas in patients with transthyretin cardiac amyloidosis 184
Cardiac magnetic resonance in patients with muscular dystrophies 183
The ergoreflex: how the skeletal muscle modulates ventilation and cardiovascular function in health and disease 182
Beta-blocking patients with cardiac amyloidosis: Adelante cum juicio 181
The Importance of Visceral Feedbacks: Focus on Chemoreceptors 181
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 181
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 178
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 178
Abdominal Fat Biopsy for the Diagnosis of Cardiac Amyloidosis 178
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 177
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 176
Discharge FGF23 level predicts one year outcome in patients admitted with acute heart failure 176
Valvular heart disease in patients with cardiac amyloidosis 175
Management of complications of cardiac amyloidosis: 10 questions and answers 175
Big gamma-glutamyltransferase is associated with epicardial fat volume and cardiovascular outcome in the general population 174
Subclinical cardiac damage in cancer patients before chemotherapy 174
Perspectives in noninvasive imaging for chronic coronary syndromes 173
Disease features and management of cardiomyopathies in women 173
Cardiac protection by pirfenidone after myocardial infarction: a bioinformatic analysis 170
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 170
Remote Ischemic Conditioning in Ischemic Stroke and Myocardial Infarction: Similarities and Differences 170
Molecular autopsy of sudden cardiac death in the genomics era 170
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis 169
Totale 27.714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 297.482
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 297.482
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.541 0 0 0 0 0 321 143 129 217 158 252 321
2021/20222.538 177 295 65 231 108 145 298 491 203 285 52 188
2022/20231.732 162 165 75 154 210 208 42 155 341 43 121 56
2023/20241.762 107 49 336 122 75 154 106 71 88 96 95 463
2024/202519.303 220 243 878 362 665 803 1.951 3.264 1.352 2.531 4.186 2.848
2025/202624.981 2.194 6.182 4.866 5.533 4.011 2.195 0 0 0 0 0 0
Totale 54.749